Olink Holding AB (publ) (NASDAQ:OLK) Shares Acquired by Tower Research Capital LLC TRC

Tower Research Capital LLC TRC lifted its stake in Olink Holding AB (publ) (NASDAQ:OLK) by 262.6% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,491 shares of the company’s stock after buying an additional 5,425 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Olink Holding AB (publ) were worth $169,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the stock. Assetmark Inc. boosted its stake in shares of Olink Holding AB (publ) by 206.2% in the first quarter. Assetmark Inc. now owns 1,424 shares of the company’s stock worth $32,000 after buying an additional 959 shares during the last quarter. Robeco Institutional Asset Management B.V. purchased a new stake in shares of Olink Holding AB (publ) in the first quarter worth about $280,000. Jennison Associates LLC boosted its stake in shares of Olink Holding AB (publ) by 54.5% in the first quarter. Jennison Associates LLC now owns 1,560,435 shares of the company’s stock worth $35,157,000 after buying an additional 550,141 shares during the last quarter. Gilder Gagnon Howe & Co. LLC boosted its position in Olink Holding AB (publ) by 2.6% during the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 75,773 shares of the company’s stock worth $1,923,000 after purchasing an additional 1,889 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its position in Olink Holding AB (publ) by 0.4% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,594,025 shares of the company’s stock worth $192,737,000 after purchasing an additional 31,332 shares in the last quarter. Hedge funds and other institutional investors own 32.25% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Morgan Stanley lowered their price target on Olink Holding AB (publ) from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 10th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, Olink Holding AB (publ) has a consensus rating of “Moderate Buy” and an average target price of $23.60.

Olink Holding AB (publ) Stock Performance

NASDAQ OLK opened at $16.14 on Wednesday. The company has a market cap of $2.01 billion, a PE ratio of -115.28 and a beta of 0.76. The stock’s 50 day simple moving average is $17.52 and its 200-day simple moving average is $20.17. Olink Holding AB has a 1-year low of $12.05 and a 1-year high of $26.47. The company has a debt-to-equity ratio of 0.01, a current ratio of 7.41 and a quick ratio of 5.84.

Olink Holding AB (publ) Profile

Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on.